Crossbow Therapeutics: Series BDevelops a novel class of potent and precise antibody therapies to treat a broad range of cancersOct 4, 2026RoundOSCrossbow TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAIBiotechUnited StatesNorth AmericaSeries B